Industry Experts

Hayretin’s background is in directed evolution and structural bioinformatics. In academia, he has worked on the interface of synthetic biology, protein engineering and computational biology developing protein switches to control cellular behavior. In the past, Hayretin has worked at Pfizer oncology where he led an antibody discovery and engineering team. He, then, joined Elanco Animal Health where he and his group built Elanco’s biotherapeutic discovery and engineering engine. At Novartis, Hayretin leads a biotherapeutics discovery group working on projects across various disease areas.